These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24698542)

  • 21. Monitoring response to treatment in asthma management: food for thought.
    Scichilone N; Deykin A; Pizzichini E; Bellia V; Polosa R
    Clin Exp Allergy; 2004 Aug; 34(8):1168-77. PubMed ID: 15298555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma.
    Carpagnano GE; Foschino Barbaro MP; Resta O; Gramiccioni E; Valerio NV; Bracciale P; Valerio G
    Eur J Pharmacol; 2005 Sep; 519(1-2):175-81. PubMed ID: 16122732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical significance of noninvasive inflammatory markers in exhaled breath condensate and induced sputum in persistent asthmatic patients].
    Tan CW; Liu CT; Wu YH
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):299-303. PubMed ID: 19576119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alveolar and airway sites of nitric oxide inflammation in treated asthma.
    Gelb AF; Taylor CF; Nussbaum E; Gutierrez C; Schein A; Shinar CM; Schein MJ; Epstein JD; Zamel N
    Am J Respir Crit Care Med; 2004 Oct; 170(7):737-41. PubMed ID: 15229098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers in asthma and allergic rhinitis.
    Diamant Z; Boot JD; Mantzouranis E; Flohr R; Sterk PJ; Gerth van Wijk R
    Pulm Pharmacol Ther; 2010 Dec; 23(6):468-81. PubMed ID: 20601050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive monitoring of bronchial inflammation in asthma.
    Sterk PJ
    Schweiz Med Wochenschr; 1997 Oct; 127(41):1686-92. PubMed ID: 9353860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
    Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
    Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting the role of exhaled nitric oxide in asthma.
    Ricciardolo FL
    Curr Opin Pulm Med; 2014 Jan; 20(1):53-9. PubMed ID: 24275926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
    Baines KJ; Simpson JL; Wood LG; Scott RJ; Fibbens NL; Powell H; Cowan DC; Taylor DR; Cowan JO; Gibson PG
    J Allergy Clin Immunol; 2014 Apr; 133(4):997-1007. PubMed ID: 24582314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control.
    Melosini L; Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Paggiaro P
    J Asthma; 2012 Apr; 49(3):317-23. PubMed ID: 22401649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exhaled breath condensate nitrates, but not nitrites or FENO, relate to asthma control.
    Malinovschi A; Pizzimenti S; Sciascia S; Heffler E; Badiu I; Rolla G
    Respir Med; 2011 Jul; 105(7):1007-13. PubMed ID: 21277184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures.
    Lemiere C
    Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):133-7. PubMed ID: 17351465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction.
    Bartoli ML; Di Franco A; Vagaggini B; Bacci E; Cianchetti S; Dente FL; Tonelli M; Paggiaro PL
    Respiration; 2009; 77(3):265-72. PubMed ID: 19075557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled corticosteroid dose reduction in childhood asthma: is nitrosopnea informative?
    Gaston B
    Am J Respir Crit Care Med; 2005 May; 171(10):1065-6. PubMed ID: 15879424
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
    Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory markers in childhood asthma.
    Dodig S; Richter D; Zrinski-Topić R
    Clin Chem Lab Med; 2011 Apr; 49(4):587-99. PubMed ID: 21303302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What role does eosinophil cationic protein have in the evaluation of asthma severity?].
    Nieto A
    Allergol Immunopathol (Madr); 2000; 28(3):119-24. PubMed ID: 10867382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.